Skip to main content
Equibles

Russell Investments Group, Ltd.

Position in LFCR — Lifecore Biomedical, Inc. De

CIK 1692234 Seattle, WA
Back to LFCR Full portfolio

Position in LFCR

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$58,794
+$33,105 QoQ
Shares Held
11,199
+62.2% QoQ
Ownership
0.030%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#60
of 98 holders
Holding Since
Mar 2020
19 quarters on record
Voting authority Sole 98% Shared 0% None 2%

Common Shares in LFCR Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Russell Investments Group, Ltd. holds $362,370,004 across 49 Drug Manufacturers - Specialty & Generic names. LFCR ranks #41 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ZTS
Zoetis Inc.
 893,500 $64,206,902
2 NBIX
Neurocrine Biosciences Inc
 329,065 $55,460,607
3 VTRS
Viatris Inc
 3,423,675 $54,367,956
4 UTHR
UNITED THERAPEUTICS Corp
 61,355 $33,243,974
5 ELAN
Elanco Animal Health Inc
 1,112,894 $27,388,318
6 LNTH
Lantheus Holdings, Inc.
 147,146 $16,324,370
7 TEVA
Teva Pharmaceutical Industries Ltd
 427,444 $14,481,798
8 ALKS
Alkermes plc.
 222,624 $11,665,496

All Filings in LFCR

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $58,794 11,199
2026-03-31 $25,689 6,906
2025-12-31 $24,179 2,956
2025-09-30 $22,528 3,061
2025-06-30 $2,094 258
2024-09-30 $414 84
2023-03-31 $902,798 238,836
2022-12-31 $1,547,655 238,836
2022-09-30 $2,593,834 291,770
2022-06-30 $2,960,569 296,948
2022-03-31 $3,385,642 292,370
2021-12-31 $3,258,825 293,588
2021-09-30 $4,982,375 540,388
2021-06-30 $8,492,938 754,928
2021-03-31 $12,515,726 1,180,729
2020-12-31 $15,474,983 1,426,266
2020-09-30 $27,403,108 2,819,250
2020-06-30 $24,147,310 3,033,582
2020-03-31 $24,401,770 2,808,029